comparemela.com

Latest Breaking News On - Jeffrey albers - Page 1 : comparemela.com

Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors

Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Jeffrey-albers
Sandra-milligan
Russell-cox
Head-of-research
Amgen-inc
Company-or-spyre
Nasdaq
Aspira-women-health
Head-of-global-regulatory-affairs
Product-development-regulatory-at-genentech-inc
Linkedin
Prnewswire-spyre-therapeutics-inc

Insiders Are Dumping These 10 Healthcare Stocks

In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping These 5 Healthcare Stocks. Healthcare-focused investors were nervous when 2024 started, since election years usually do not bode well for the healthcare industry amid policy-related uncertainties. But healthcare stocks […]

Poland
Polen
David-schlanger
Alanm-garber
Jill-carroll
Mark-livingston
Jeffrey-albers
Novo-nordisk
Luis-louro
Patrickj-haley
Exelixis-inc
Blueprint-medicines-corp

Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
Israel
Ukraine
China
Laurie-stelzer
Jeffrey-albers
Markc-mckenna
Colitis-organisation
Research-development-asset
Exchange-commission
Company-seriesa-preferred-stock
Prometheus-biosciences-inc

Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Israel
China
Ukraine
Jeffrey-albers
Laurie-stelzer
Markc-mckenna
Company-seriesa-preferred-stock
Company-board-of-directors
Linkedin
Development-pipeline-overview
Nasdaq

Director Jeffrey Albers Sells 10,000 Shares of Kymera Therapeutics Inc

On January 23, 2024, Jeffrey Albers, a director at Kymera Therapeutics Inc (NASDAQ:KYMR), executed a sale of 10,000 shares of the company's stock, as reported in a recent SEC Filing.

Kymera-therapeutics-inc-is-fairly
Kymera-therapeutics-inc
Gurufocus-value
Fairly-valued
Biotechnology-company
Jeffrey-albers

vimarsana © 2020. All Rights Reserved.